India, Feb. 12 -- Biotechnology company Biogen, Inc. (BIIB) reported Wednesday that net income attributable to the company for the fourth quarter grew to $266.8 million or $1.83 per share from $249.7 million or $1.71 per share in the prior-year quarter.
Excluding items, adjusted earnings for the quarter were $3.44 per share, compared to $2.95 per share in the year-ago quarter.
On average, 26 analysts polled expected the company to report earnings of $3.36 per share for the quarter. Analysts' estimates typically exclude special items.
Total revenue for the quarter grew 2.9 percent to $2.46 billion from $2.39 billion in the same quarter last year. Revenues were up 2.4 percent in constant currency. Analysts expected revenues of $2.42 billio...